(3-275) Evaluating Use of Intranasal Esketamine in Treatment-Resistant Major Depressive Disorder (MDD) Treated Adjunctively with Oral Antidepressant

Monday, December 5, 2022

12:00 PM – 1:00 PM

Location: Bayside A, Level 1

Category: Descriptive Report
Topic: Drug Information/Drug Use Evaluation

Co-Author(s): Hannah Chapman, Jayne Lepage

Primary Author(s)